Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Immunotherapy. 2013 Oct;5(10):10.2217/imt.13.102. doi: 10.2217/imt.13.102

Table 1.

Targeting strategies for tumor-associated macrophages in mouse models.

Target or drug Mechanism of action
CCL2-CCR2 axis Prevents monocyte recruitment
CSF1-CSF1R axis Inhibits/reprograms TAMs
CXCL12-CXCR4 axis Prevents recruitment of macrophages
DNA repair mechanisms (trabectedin) Targets TAMs
Clodronate and zoledronic acid Induces macrophage apoptosis
Anti-CpG and IL-10 Ab Prevents antitumor to protumor macrophage
polarization
CD40 agonist Restores tumor immunity
Sibilin Suppresses NF-κB and STAT3
phosphorylation, blocks angiogenesis

Ab: Antibody; CSF1R: CSF1 receptor; TAM: Tumor-associated macrophage.